Literature DB >> 11231585

The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27.

D Ganoth1, G Bornstein, T K Ko, B Larsen, M Tyers, M Pagano, A Hershko.   

Abstract

The cyclin-dependent kinase (CDK) inhibitor p27 is degraded in late G1 phase by the ubiquitin pathway, allowing CDK activity to drive cells into S phase. Ubiquitinylation of p27 requires its phosphorylation at Thr 187 (refs 3, 4) and subsequent recognition by S-phase kinase associated protein 2 (Skp2; refs 5-8), a member of the F-box family of proteins that associates with Skp1, Cul-1 and ROC1/Rbx1 to form an SCF ubiquitin ligase complex. However, in vitro ligation of p27 to ubiquitin could not be reconstituted by known purified components of the SCFSkp2 complex. Here we show that the missing factor is CDK subunit 1 (Cks1), which belongs to the highly conserved Suc1/Cks family of proteins that bind to some CDKs and phosphorylated proteins and are essential for cell-cycle progression. Human Cks1, but not other members of the family, reconstitutes ubiquitin ligation of p27 in a completely purified system, binds to Skp2 and greatly increases binding of T187-phosphorylated p27 to Skp2. Our results represent the first evidence that an SCF complex requires an accessory protein for activity as well as for binding to its phosphorylated substrate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231585     DOI: 10.1038/35060126

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  181 in total

1.  NEDD8 recruits E2-ubiquitin to SCF E3 ligase.

Authors:  T Kawakami; T Chiba; T Suzuki; K Iwai; K Yamanaka; N Minato; H Suzuki; N Shimbara; Y Hidaka; F Osaka; M Omata; K Tanaka
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

Review 2.  SCF ubiquitin ligase-targeted therapies.

Authors:  Jeffrey R Skaar; Julia K Pagan; Michele Pagano
Journal:  Nat Rev Drug Discov       Date:  2014-11-14       Impact factor: 84.694

3.  Protein-protein interactions involved in the recognition of p27 by E3 ubiquitin ligase.

Authors:  Kui Xu; Charles Belunis; Wei Chu; David Weber; Frank Podlaski; Kuo-Sen Huang; Steven I Reed; Lyubomir T Vassilev
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

4.  Noncatalytic requirement for cyclin A-cdk2 in p27 turnover.

Authors:  Xin-Hua Zhu; Hoang Nguyen; H Dorota Halicka; Frank Traganos; Andrew Koff
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

5.  Dynamic changes of PIRH2 and p27kip1 expression in injured rat sciatic nerve.

Authors:  Honghui Li; Jie Deng; Haili Chen; Tao Chen; Xiang Cao; Huibao Hou; Weipeng Huan; Guowei Zhang; Biyun Yu; Youhua Wang
Journal:  Neurol Sci       Date:  2011-09-30       Impact factor: 3.307

6.  MicroRNA-936 induces cell cycle arrest and inhibits glioma cell proliferation by targeting CKS1.

Authors:  Dong Wang; Tongle Zhi; Xiupeng Xu; Zhongyuan Bao; Liang Fan; Zheng Li; Jing Ji; Ning Liu
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

7.  The F-box subunit of the SCF E3 complex is encoded by a diverse superfamily of genes in Arabidopsis.

Authors:  Jennifer M Gagne; Brian P Downes; Shin-Han Shiu; Adam M Durski; Richard D Vierstra
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-08       Impact factor: 11.205

8.  Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation.

Authors:  Shojiro Kitajima; Yasusei Kudo; Ikuko Ogawa; Tarig Bashir; Masae Kitagawa; Mutsumi Miyauchi; Michele Pagano; Takashi Takata
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

9.  CKS1BP7, a Pseudogene of CKS1B, is Co-Amplified with IGF1R in Breast Cancers.

Authors:  Yansong Liu; Wei Wang; Yan Li; Feifei Sun; Jiaxiang Lin; Li Li
Journal:  Pathol Oncol Res       Date:  2017-04-24       Impact factor: 3.201

Review 10.  p27 deregulation in breast cancer: prognostic significance and implications for therapy.

Authors:  A Alkarain; R Jordan; J Slingerland
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.